Published On: Mon, Oct 26th, 2015

Drugmaker Valeant raises detailed defense but doubts remain – Reuters Canada


Toronto Star

Drugmaker Valeant raises detailed defense but doubts remain
Reuters Canada
(Reuters) – Drugmaker Valeant Pharmaceuticals International Inc VRX.TO VRX.N laid out a detailed defense on Monday of its relationship with a little-known specialty pharmacy, but its arguments failed to calm all investor concerns. Valeant shares have
Valeant bonds stabilize after analyst callThe Globe and Mail
Valeant asks US Securities and Exchange Commission to investigate CitronThe Province
Glancy Prongay & Murray LLP Announces the Filing of a Securities Class Action Stockhouse
The Motley Fool Canada –BlackburnNews.com –Southern Investigative Reporting Foundation –CitronResearch.com
all 497 news articles »

Business – Google News

About the Author

-

Leave a comment

XHTML: You can use these html tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Videos

Subscribe to Our Newsletter

Get our latest downloads and information first. Complete the form below to subscribe to our weekly newsletter.

Your Name (required)
Your Email (required)

I would like to hear from selected 3rd party offers
Answer this?

/